Edition:
India

Allergan To Present Vraylar Data At The American Psychiatric Association 2019 Annual Meeting


Wednesday, 15 May 2019 

May 15 (Reuters) - Allergan plc ::ALLERGAN TO PRESENT VRAYLAR® (CARIPRAZINE) DATA AT THE AMERICAN PSYCHIATRIC ASSOCIATION (APA) 2019 ANNUAL MEETING HIGHLIGHTING CONTINUED COMMITMENT TO MENTAL HEALTH.ALLERGAN - FDA ACTION ON SUPPLEMENTAL NEW DRUG APPLICATION FOR VRAYLAR FOR TREATMENT OF BIPOLAR DEPRESSION IS EXPECTED IN FIRST HALF THIS YEAR.